| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.14 | 0.004 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.14 | 0.4 |
| mRNA | BI-2536 | FIMM | pan-cancer | AAC | -0.13 | 0.3 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.12 | 0.5 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.11 | 0.6 |